- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/69 - Benzenesulfonamido-pyrimidines
Patent holdings for IPC class C07D 239/69
Total number of patents in this class: 85
10-year publication summary
|
5
|
6
|
5
|
7
|
10
|
6
|
4
|
1
|
0
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Xenon Pharmaceuticals Inc. | 193 |
7 |
| Vertex Pharmaceuticals Incorporated | 1578 |
5 |
| ESSA Pharma Inc. | 34 |
5 |
| Eastern Virginia Medical School | 64 |
3 |
| The Regents of the University of California, Santa Cruz | 17 |
3 |
| Thomas Jefferson University | 557 |
3 |
| University of Dundee | 219 |
3 |
| ZaCh System S.p.A. | 21 |
3 |
| BASF SE | 21334 |
2 |
| Genentech, Inc. | 4157 |
2 |
| FUJIFILM Corporation | 30808 |
2 |
| ADAMA Agan Ltd. | 451 |
2 |
| Generics [UK] Limited | 106 |
2 |
| Genzyme Corporation | 1383 |
2 |
| Sanford-Burnham Medical Research Institute | 123 |
2 |
| The United States of America Department of Health | 2 |
2 |
| Novartis AG | 10170 |
1 |
| AstraZeneca AB | 2831 |
1 |
| AstraZeneca UK Limited | 509 |
1 |
| Massachusetts Institute of Technology | 10322 |
1 |
| Other owners | 33 |